Madhya Pradesh High Court grants bail to two in Chhindwara toxic cough syrup case

Jabalpur: Two medical representatives arrested in last year’s alleged toxic cough syrup case in Chhindwara, which killed over 20 children, have been granted conditional bail by the Madhya Pradesh High Court, their lawyer said on Wednesday.

A single bench of Justice Ajay Kumar Nirankari granted relief to the two accused on Tuesday, he said.

In their petition, Satish Verma and Shailesh Singh Pandya had submitted that they had no connection to the production of the toxic cough syrup, and as medical representatives, they had simply placed orders with the company for supplies and were unaware of any adulteration or defects in the medicine.

Besides, they also had no role in the storage, distribution, or destruction of the drug, their petition said.

The police have completed the investigation and submitted relevant documents to the court. “The hearing of the case may take time. Applicants Satish Verma and Shailesh Singh Pandya have been in judicial custody since October 2025 and November 2025, respectively,” said Sankalp Kochhar, who represented the duo.

However, the government opposed the bail applications, saying the two were accused of playing a role in the promotion of the controversial cough syrup, the supply chain and the development of a prescription network of doctors.

The applicants acted as the key link between the main accused Dr Praveen Soni, and the pharmaceutical company. The investigation has found significant evidence against the applicants, the prosecution said.

After hearing the applications, the single bench granted conditional bail to both the accused, Kochhar said.

In October 2025, children in Chhindwara district began falling ill after consuming Coldrif cough syrup, with complaints of vomiting, inability to urinate and fever.

Investigations showed that the syrup contained diethylene glycol, a toxic chemical that causes kidney failure. The company owner and a government doctor, who allegedly recommended the syrup, were arrested in the case.

A sample of the syrup, tested by a government Drug Testing Laboratory in Chennai, was declared “Not of Standard Quality” by the Tamil Nadu Directorate of Drug Control, officials had said.

Related Posts

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses